AI/ML Innovations Inc. (CSE: $AIML) turns AI & ML into clearer biometrics and smarter healthcare. Investing in digital-health tech that uplifts lives worldwide.
$AIML has been granted U.S. Patent No. 12,465,266 for its ECG signal-processing neural network - covering denoising, wave analysis & rhythm detection.
With no prior art, this patent reinforces AIML’s IP strength in biometric signal processing
Full PR: accessnewswire.com/newsroom/…
Your heart runs its own neural network command centre - no brain required. The heart's 40,000 embedded neurons self-regulate rhythm & function independently. Even transplanted hearts self-regulate🫀
Learn More in our latest article: linkedin.com/pulse/your-hear…
$AIML Subsidiary NeuralCloud Appoints Dale & Nicholas DuBois to lead clinical and overread operations. This brings decades of experience & strengthens governance as its ECG signal-processing technology advances through regulatory review toward future commercialization.
The AI ECG analysis market is set to surpass $5B by 2030 at 18% CAGR - arrhythmia detection is the #1 use case, North America leads, and cloud-based AI will capture 56% of market value. Telehealth and ambulatory monitoring are driving the scale.
$AIMLnatlawreview.com/press-relea…
$AIML Appoints Dr. Martin Green to Medical Advisory Board: Founding architect of Canadian cardiac electrophysiology and 45-year ECG authority joins AIML's MAB - extending national clinical coverage to University of Ottawa Heart Institute
Full PR: aiml-innovations.com/press-r…
If you missed April's edition of The Pulse Newsletter, here's the latest from $AIML:
→ Paul Duffy launches the Signal & Noise Series on Substack
→ Baker Heart HRV research partnership
→ MaxYield™ plugs into European ECG platform
→ What does AFib look like on an ECG?
Paul Duffy's SubStack kicks off a series on signal noise, technician burnout, and flawed algorithms breaking the ECG system:
• Noisy datasets
• Manual review burden
• Missed diagnoses
Signal-first AI may be the fix.
Read full article: paulduffy.substack.com/p/the…
If you're following $AIML, make it easy on yourself.
The Pulse - our monthly newsletter - covers milestones, partnerships, and product updates. Get press releases and announcements in your inbox, as they happen.
Subscribe: health.us3.list-manage.com/s…
"One of the world's foremost neural networks on labeling ECG data."
- Paul Duffy, CEO $AIML
1 heartbeat or 3,000,000 recorded over a month.
Processed in moments. Most feature-rich ECG output from any single recording.
18 months in the making.
Watch → youtube.com/shorts/Xv6siHla_…
$AIML Signs Reseller Agreement with European Digital Cardiac Monitoring Platform:
Neural Cloud will integrate MaxYield, transforming raw ECG signals into clean, machine-readable data for remote cardiac monitoring & advanced heart rate variability (HRV) analytics.
CEO Paul Duffy on why $AIML may be undervalued, and what changes that.
▸ Growing IP portfolio
▸ MaxYield™ approaching 510(k) clearance
Multiple markets. FDA clearance IP portfolio with no prior art.
Watch → youtube.com/shorts/-qPJpZYlR…
NeuralCloud has entered a research services agreement with the Baker Heart and Diabetes Institute - one of the world's leading cardiovascular research organizations - to process ECG recordings into structured, beat-level datasets ready for Heart Rate Variability analysis.
$AIML
MaxYield = Maximum Diagnostic Yield.
The name reflects what the neural network does: extract every usable piece of cardiac data from an ECG recording. No hardware redesign. No rebuilding your signal stack
$AIML
Full Clip: youtube.com/shorts/MEbkdkAUs…
Most ECG algorithms were built for a human lying still in a clinic. Animal ECG demands different signal intelligence
Horses generate extreme motion artifact. Species-specific waveform morphologies break traditional peak detection.
MaxYield for Animals: theneuralcloud.com/animal-ve…
Continuous ECG is gaining traction in wellness & performance tracking.
As accuracy becomes more important for recovery, sleep, and training insights, ECG-based approaches are starting to outvalue traditional PPG-based wearables.
$AIML
🎥 youtube.com/shorts/nwvo5k9FF…
The ECG patch and Holter monitor market is set to nearly quadruple by 2030, from USD 1,189.5M (2022) to USD 4,835.3M by 2030, at 19.2% CAGR. AFib prevalence, aging populations, and adoption of remote & wearable monitoring solutions are key drivers.
$AIMLgrandviewresearch.com/indust…
CEO Paul Duffy just laid out the $AIML 6-month roadmap - Small team. A handful of deals to get to break-even. Technologies ready to deploy.
2026 is the year the commercialization story starts.
Full Clip: youtube.com/shorts/6rf153_XI…